PETS PetMed Express Inc.

PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website and mobile app; telephone contact center; and direct mail/print through catalogs, brochures, and postcards. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Date	Price Target	Rating	Analyst
5/25/2023	$20.00	Buy	Lake Street
1/25/2022	$25.00 → $21.00	Underweight	Morgan Stanley
1/20/2022	$32.00	Neutral → Buy	Sidoti
11/18/2021	$25.00	Underweight	Morgan Stanley
10/1/2021	$28.00	Hold	Jefferies
8/5/2021	$22.00	Underperform	Credit Suisse

PetMed Express Inc.

Peers

Recent Analyst Ratings for PetMed Express Inc.

PetMed Express Inc. SEC Filings

PetMed Express Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

SEC Form NT 10-K filed by PetMed Express Inc.

PetMed Express Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form 10-Q filed by PetMed Express Inc.

PetMed Express Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Amendment: SEC Form SCHEDULE 13G/A filed by PetMed Express Inc.

Amendment: PetMed Express Inc. filed SEC Form 8-K: Financial Statements and Exhibits

PetMed Express Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form 8-A12B filed by PetMed Express Inc.

SEC Form 10-Q filed by PetMed Express Inc.

PetMed Express Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Large owner Nina Capital Holdings Inc. bought $98,375 worth of shares (25,000 units at $3.94), increasing direct ownership by 0.99% to 2,550,000 units (SEC Form 4)

Large owner Nina Capital Holdings Inc. bought $96,500 worth of shares (25,000 units at $3.86), increasing direct ownership by 1% to 2,525,000 units (SEC Form 4)

Large owner Silvercape Investments Ltd bought $29,234 worth of shares (7,401 units at $3.95), increasing direct ownership by 0.32% to 2,307,719 units (SEC Form 4)

New insider Silvercape Investments Ltd claimed ownership of 2,300,318 shares (SEC Form 3)

CEO & President Campos Sandra Yvette sold $200,090 worth of shares (60,463 units at $3.31), decreasing direct ownership by 9% to 578,524 units (SEC Form 4)

Director Batushansky Peter was granted 2,527 shares (SEC Form 4)

SEC Form 3 filed by new insider Batushansky Peter

Large owner Nina Capital Holdings Inc. bought $408,500 worth of shares (100,000 units at $4.08), increasing direct ownership by 4% to 2,500,000 units (SEC Form 4)

Large owner Nina Capital Holdings Inc. bought $411,000 worth of shares (100,000 units at $4.11), increasing direct ownership by 4% to 2,400,000 units (SEC Form 4)

Large owner Nina Capital Holdings Inc. bought $216,250 worth of shares (50,000 units at $4.33), increasing direct ownership by 2% to 2,300,000 units (SEC Form 4)